These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15986076

  • 1. Mycophenolate mofetil: a dermatologic perspective.
    Mydlarski PR.
    Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil in dermatology.
    Orvis AK, Wesson SK, Breza TS, Church AA, Mitchell CL, Watkins SW.
    J Am Acad Dermatol; 2009 Feb; 60(2):183-99; quiz 200-2. PubMed ID: 19150270
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolic acid in dermatology a century after its discovery.
    Strathie Page SJ, Tait CP.
    Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mycophenolate in dermatology.
    Liu V, Mackool BT.
    J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.
    Takebe N, Cheng X, Wu S, Bauer K, Goloubeva OG, Fenton RG, Heyman M, Rapoport AP, Badros A, Shaughnessy J, Ross D, Meisenberg B, Tricot G.
    Clin Cancer Res; 2004 Dec 15; 10(24):8301-8. PubMed ID: 15623606
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC, Eugui EM.
    Clin Transplant; 1996 Feb 15; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic monitoring of mycophenolate mofetil.
    Budde K, Glander P, Bauer S, Braun K, Waiser J, Fritsche L, Mai I, Roots I, Neumayer HH.
    Clin Chem Lab Med; 2000 Nov 15; 38(11):1213-6. PubMed ID: 11156363
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Mycophenolate mofetil--20 years of experience in treatment of rheumatic diseases].
    Walkiewicz-Pielaszek K, Swacha M, Bułło-Piontecka B, Rutkowski B, Olesiñska M.
    Postepy Hig Med Dosw (Online); 2015 Feb 06; 69():176-87. PubMed ID: 25661917
    [Abstract] [Full Text] [Related]

  • 18. From mechanisms to long-term benefits.
    Mamelok R.
    Transplantation; 2005 Feb 15; 79(3 Suppl):S43-4. PubMed ID: 15699749
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.